T. Rowe Price Associates »

Abeona Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $139k 31k 4.48
2025-12-31 $128k 24k 5.31
2025-09-30 $123k 23k 5.31
2025-06-30 $125k 22k 5.71

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Abeona Therapeutics

Nantahala Capital Management
BlackRock
Cable Car Capital
AIGH Capital Management
Vanguard Capital Management
Resources Investment Advisors
AWM Investment Company
Geode Capital Management
Kennedy Capital Management
Goldman Sachs Group
Propel Bio Management
State Street Corporation
Nan Fung Trinity
Diametric Capital
J. Goldman & Co

View all funds holding Abeona Therapeutics